Variability in caco-2 and MDCK cell-based intestinal permeability assays

Journal of Pharmaceutical Sciences

Volumn 97, Issue 2, 2008, Pages 712-725

  Volpe, Donna A ^a  

^a Division of Product Quality Research   (United States)

Author keywords

Caco 2; In vitro; Intestinal permeability; MDCK; Variability

Indexed keywords

ACYLTRANSFERASE; ALKALINE PHOSPHATASE; ALPRENOLOL; ATENOLOL; BUFFER; CHLOROTHIAZIDE; CIMETIDINE; DEXAMETHASONE; DIGOXIN; DILTIAZEM; DIPEPTIDYL PEPTIDASE IV; EPHEDRINE; FUROSEMIDE; GLUTATHIONE TRANSFERASE; GLYCOPROTEIN P; HYDROCHLOROTHIAZIDE; LACTASE; MICROSOMAL AMINOPEPTIDASE; MULTIDRUG RESISTANCE PROTEIN; NAPROXEN; PEPTIDASE; PEPTIDE TRANSPORTER 1; PHENYTOIN; PINDOLOL; PROPRANOLOL; SALICYLIC ACID; SUCRASE ISOMALTASE; SULFOTRANSFERASE; THEOPHYLLINE; UNINDEXED DRUG;

ACTIVE TRANSPORT; ANIMAL CELL; CELL AGING; CELL DENSITY; CELL STRAIN; CELL STRAIN CACO 2; CONTROLLED STUDY; CULTURE MEDIUM; DRUG ABSORPTION; DRUG TRANSPORT; INTESTINE MUCOSA PERMEABILITY; LABORATORY; MEMBRANE FILTER; NONHUMAN; PASSIVE TRANSPORT; REVIEW;

EID: 39749114622     PISSN: 00223549     EISSN: 15206017     Source Type: Journal    
DOI: 10.1002/jps.21010     Document Type: Review

References (117)

1. Hidalgo IJ, Raub TJ, Borchardt RT. 1989. Characterization of the human colon carcinoma cell line (Caco-2) as a model system for intestinal epithelial permeability. Gastroenterology 96:736-749.
2. Fogh J, Fogh JM, Orfeo T. 1977. One hundred and twenty-seven cultured human tumor cell lines producing tumors in nude mice. J Natl Cancer Inst 59:221-225.
3. Grasset E, Pinto M, Dussaulx E, Zweibaum A, Desjeux JF. 1984. Epithelial properties of human colonic carcinoma cell line Caco-2: Electrical parameters. Am J Physiol 247:C260-C267.
4. Pinto M, Robin-Leon S, Appay MD, Kedinger M, Triadou N, Dussaulx E, Lacroix B, Simon-Assman P, Haffen K, Fogh J, Zweibaum A. 1983. Enterocyte-like differentiation and polarization of the human colon carcinoma cell line Caco-2 in culture. Biol Cell 47:323-330.
5. Chantret I, Barbat A, Dussaulx E, Brattain MG, Zweibaum A. 1988. Epithelial polarity, villin expression and enterocytic differentiation of cultured human colon carcinoma cells: A survey of twenty cell lines. Cancer Res 48:1936-1942.
6. Engle MJ, Goetz GS, Alpers DH. 1998. Caco-2 cells express a combination of colonocyte and enterocyte phenotypes. J Cell Physiol 174:362-369.
7. Walter E, Kissel T. 1995. Heterogeneity in the human intestinal cell line Caco-2 leads to differences in transepithelial transport. Eur J Pharm Sci 3:215-230.
8. Herold G, Rogler G, Rogler D, Stange EF. 1994. Morphology of CaCo-2 cells varies in different cell batches. In Vitro Cell Dev Biol Anim 30A:289-291.
9. Prueksaritanont T, Gorham LM, Hochman JH, Tran LO, Vyas KP. 1996 Comparative studies of drug-metabolizing enzymes in dog, monkey, and human small intestines, and in Caco-2 cells. Drug Metab Dispos 24:634-642.
10. Hosoya HI, Kim KJ, Lee VHL. 1996. Age-dependent expression of P-glycoprotein gp170 in Caco-2 cell monolayers. Pharm Res 13:885-890.
11. Li Q, Sai Y, Kato Y, Tamai I, Tsuji A. 2003. Influence of drugs and nutrients on transporter gene expression levels in Caco-2 and LS180 intestinal epithelial cell lines. Pharm Res 20:1119-1124.
12. Hunter J, Jepson MA, Tsuruo T, Simmons NL, Hirst BH. 1993. Functional expression of P-glycoprotein in apical membranes of human intestinal Caco-2 cells. Kinetics of vinblastine secretion and interaction with modulators. J Biol Chem 268: 14991-14997.
13. Taipalensuu J, Tornblom H, Lindberg G, Einarsson C, Sjoqvist F, Melhus H, Garberg P, Sjostrom B, Lundgren B, Artursson P. 2001. Correlation of gene expression of ten efflux proteins of the ATP-binding cassette transporter family in normal human jejunum and in human intestinal epithelial Caco-2 cell monolayers. J Pharmacol Exp Ther 299:164-170.
14. Englund G, Rorsman F, Rönnblom A, Karlbom U, Lazorval L, Gråsjö J, Kindmark A, Artursson P. 2006. Regional levels of drug transporters along the human intestinal tract: Co-expression of ABC and SLC transporters and comparison with Caco-2 cells. Eur J Pharm Sci 29:269-277.
15. +-dependent sugar transport in Caco-2 cells and human fetal colon. J Membr Biol 99:113-125.
16. Mahraoui L, Rodolosse A, Barbat A, Dussaulx E, Zweibaum A, Rousset M, Brot-Laroche E. 1994. Presence and differential expression of SGLT1, GLUT1, GLUT2, GLUT3 and GLUT5 hexose transporter mRNAs in Caco-2 clones in relation to cell growth and glucose consumption. Biochem J 298:629-633.
17. Hidalgo IJ, Borchardt RT. 1990. Transport of bile acids in a human intestinal epithelial cell line, Caco-2. Biochim Biophys Acta 1035:97-103.
18. Hu M, Borchardt RT. 1990. Mechanism of L-alpha-methyldopa transport through a monolayer of polarized human intestinal epithelial cells (Caco-2). Pharm Res 7:1313-1319.
19. Hidalgo IJ, Borchardt RT. 1990. Transport of a large neutral amino acid (phenylalanine) in a human intestinal epithelial cell line: Caco-2. Biochim Biophys Acta 1028:25-30.
20. Nicklin PL, Irwin WJ, Hassan IF, Mackay M, Dixon HB. 1995. The transport of acidic amino acids and their analogues across monolayers of human intestinal absorptive (Caco-2) cells in vitro. Biochim Biophys Acta 1269:176-186.
21. Mason JB, Shoda R, Haskell M, Selhub J, Rosenberg IH. 1990. Carrier affinity as a mechanism for the pH-dependence of folate transport in the small intestine. Biochim Biophys Acta 1024:331-335.
22. Ng KY, Borchardt RT. 1993. Biotin transport in a human intestinal epithelial cell line (Caco-2). Life Sci 53:1121-1127.
23. Saito H, Inui K. 1993. Dipeptide transporters in apical and basolateral membranes of the human intestinal cell line Caco-2. Am J Physiol 265:G289-G294.
24. +-coupled absorption. Br J Pharmacol 113:1050-1056.
25. Dantzig AH, Bergin L. 1990. Uptake of the cephalosporin, cephalexin, by a dipeptide transport carrier in the human intestinal cell line, Caco-2. Biochim Biophys Acta 1027:211-217.
26. Hu M. 1993. Comparison of uptake characteristics of thymidine and zidovudine in a human intestinal epithelial model system. J Pharm Sci 82:829-833.
27. +-independent transport systems in T84 and Caco-2 cells. Biochim Biophys Acta 1419: 15-22.
28. Takanaga H, Tamai I, Tsuji A. 1994. pH-dependent and carrier-mediated transport of salicylic acid across Caco-2 cells. J Pharm Pharmacol 46: 567-570.
29. Ng KH, Lim BG, Wong KP. 2003. Sulfate conjugating and transport functions of MDCK distal tubular cells. Kidney Int 63:976-986.
30. Letellier M, Briere N, Plante GE, Petitclerc C. 1987. Phosphate transport and alkaline phosphatase in confluent MDCK cell monolayers. Can J Physiol Pharmacol 65:1151-1156.
31. Bohets HH, Nouwen EJ, De Broe ME, Diereckx PJ. 1996. The cytosolic glutathione S-transferase isoenzymes in the dog kidney cortex as compared with the corresponding MDCK renal cell line. Biochim Biophys Acta 1311:93-101.
32. Putman W, Ramanathan S, Pan L, Takahashi L, Benet LZ. 2002. Functional characterization of monocarboxylix acid, large neutral amino acid, bile acid and peptide transporters, and P-glycoprotein in MDCK and Cao-2 cells. J Pharm Sci 91:2622-2635.
33. Hunter J, Hirst BH, Simmons NL. 1993. Transepithelial secretion, cellular accumulation, and cytotoxicity of vinblastine in defined MDCK cell strains. Biochim Biophys Acta 1179:1-10.
34. Horio M, Chin KV, Currier SJ, Goldenburg S, Williams C, Pastan J, Gottesman MM, Handler J. 1989. Transepithelial transport of drugs by the multidrug transporter in cultured Madin-Darby canine kidney cell epithelia. J Biol Chem 264: 14880-14884.
35. Shu Y, Bello CL, Mangravite LM, Feng B, Giacomini KM. 2001. Functional characteristics and steroid-hormone mediated regulation of an organic cation transporter in Madin-Darby canine kidney cells. J Pharmacol Exp Ther 299:392-398.
36. +-peptide cotransportation in Madin-Darby canine kidney cells: Expression and calmodulin-dependent regulation. Am J Physiol 268:F391-F397.
37. Terada T, Sawada K, Ito T, Saito H, Hashimoto Y, Inui KI. 2000. Functional expression of novel peptide transporter in renal basolateral membranes. Am J Physiol 279:F851-F857.
38. Artursson P, Karlsson J. 1991. Correlation between oral drug absorption in humans and apparent drug permeability coefficients in human intestinal epithelial (Caco-2) cells. Biochem Biophys Res Commun 175:880-885.
39. Lennernas H, Palm K, Fagerholm U, Artursson P. 1996. Comparison between active and passive drug transport in human intestinal epithelial (Caco-2) cells in vitro and human jejunum in vivo. Intl J Pharm 127:103-107.
40. Grès MC, Julian B, Bourrié M, Meunier V, Roques C, Berger M, Boulenc X, Berger Y, Fabre G. 1998. Correlation between oral drug absorption in humans, and apparent drug permeability in TC-7 cells, a human epithelial intestinal cell line: Comparison with the parental Caco-2 cell line. Pharm Res 15:726-733.
41. Biganzoli E, Cavenaghi LA, Rossi R, Brunati MC, Nolli ML. 1999. Use of Caco-2 cell culture model for the characterization of intestinal absorption of antibiotics. Il Farmaco 54:594-599.
42. Volpe DA, Ciavarella AB, Asafu-Adjaye EB, Ellison CD, Faustino PJ, Yu LX. 2001. Method suitability of a Caco-2 cell model for drug permeability classification. AAPS PharmSci 3: abstract 425.
43. Irvine JD, Takahashi L, Lockhart K, Cheong J, Tolan JW, Selick HE, Grove JR. 1999. MDCK (Madin-Darby canine kidney) cells: A tool for membrane permeability screening. J Pharm Sci 88: 28-33.
44. Cho MJ, Thompson DP, Cramer CT, Vidmar TJ, Scieszka JF. 1989. The Madin Darby canine kidney (MDCK) epithelial cell monolayer as a model cellular transport barrier. Pharm Res 6:71-77.
45. Misfeldt DS, Hamamoto ST, Pitelka DR. 1976. Transepithelial transport in cell culture. Proc Natl Acad Sci USA 73:1212-1216.
46. Cereijido M, Robbins ES, Dolan WJ, Rotunno CA, Sabatini DD. 1978. Polarized monolayers formed by epithelial cells on a permeable and translucent support. J Cell Biol 77:853-880.
47. Simmons NL. 1982. Cultured monolayers of MDCK cells: A novel model system for the study of epithelial development and function. Gen Pharmacol 13:287-291.
48. Rothen-Rutishauser B, Krämer SD, Braun A, Günthert M, Wunderli-Allenspach H. 1998. MDCK cell cultures as an epithelial in vitro model: Cytoskeleton and tight junction as indicators for the definition of age-related stages by confocal microscopy. Pharm Res 15:964-971.
49. Husted R, Welsh M, Stokes J. 1986. Variability of functional characteristics of MDCK cells. Am J Physiol 250:C214-C221.
50. Arthur JM. 2000. The MDCK cell line is made up of populations of cells with diverse resistive and transport properties. Tissue Cell 32:446-450.
51. Spicer N, Yu H, Janosky B, Doan VK, Wei D, Laws K, Rooney M, Hardy LW, Chan OH. 2002. Examination of the MDCK-II cell as an intestinal model for permeability screening. AAPS PharmSci 4: abstract 2224.
52. Volpe DA, Faustino PJ, Yu LX, Hussain AS. 2001. Towards standardization of an in vitro method of drug absorption. Pharm Forum 27:2916-2922.
53. Volpe DA, Yu LX, Möller H. 2002. Regulatory acceptance of in vitro permeability studies ands in the context of the biopharmaceutics classification system. In: Lehr CM, editor. Cell culture models of biological barriers: In-vitro test systems for drug absorption and delivery. London: Taylor & Francis. pp 130-139.
54. Borchardt RT. 1994. Rational delivery strategies for the design of peptides with enhanced oral delivery. Drug Dev Ind Pharm 20:469-483.
55. Meunier V, Bourrié M, Berger Y, Fabre G. 1995. The human intestinal epithelial cell line Caco-2; pharmacological and pharmacokinetic applications. Cell Biol Toxicol 11:187-194.
56. Audus KL, Bartel RL, Hidalgo IJ, Borchardt RT. 1990. The use of cultured epithelial and endothelial cells for drug transport and metabolism studies. Pharm Res 7:435-451.
57. Bailey CA, Bryla P, Malick AW. 1996. The use of the intestinal epithelial cell culture model, Caco-2, in pharmaceutical development. Adv Drug Deliv Rev 22:85-103.
58. Delie F, Rubas W. 1997. A human colonic cell line sharing similarities with enterocytes as a model to examine oral absorption: Advantages and limitations of the Caco-2 model. Crit Rev Ther Drug Carrier Syst 14:221-286.
59. Briske-Anderson MJ, Finley JW, Newman SM. 1997. The influence of culture time and passage number on the morphological and physiological development of Caco-2 cells. Proc Soc Expt Biol Med 214:248-257.
60. Hidalgo IJ. 2001. Assessing the absorption of new pharmaceuticals. Curr Topics Med Chem 1:385-401.
61. Hillgren KM, Kato A, Borchardt RT. 1995. In vitro systems for studying intestinal drug absorption. Med Res Rev 15:83-109.
62. Vachon PH, Beaulieu JF. 1992. Transient mosaic patterns of morphological and functional differentiation in the Caco-2 cell line. Gastroenterology 103:414-423.
63. Artursson P. 1991. Cell cultures as models for drug absorption across the intestinal mucosa. Crit Rev Ther Drug Carrier Syst 8:305-330.
64. Nicklin P, Irwin B, Hassan I, Williamson I, Mackay M. 1992. Permeable support type influences the transport of compounds across Caco-2 cells. Intl J Pharm 83:197-209.
65. Kumpf SL, Ribabeneira MD, Sharpe D, Link J, Huber R, Burton C, Aungst B. 2001. Isolation and characterization of Caco-2 cells expressing high and low levels of P-glycoprotein. AAPS PharmSci 3: abstract 1383.
66. Behrens I, Kamm W, Dantzig AH, Kissel T. 2004. Variation of peptide transporter (PepT1 and HPT1) expression in Caco-2 cells as a function of cell origin. J Pharm Sci 93:1743-1754.
67. Richardson JCW, Scalera V, Simmons NL. 1981. Identification of two strains of MDCK cells which resemble separate nephron tubule segments. Biochim Biophys Acta 673:26-36.
68. Yu H, Cook TJ, Sinko PJ. 1997. Evidence for diminished functional expression of intestinal transporters in Caco-2 cell monolayers at high passages. Pharm Res 14:757-762.
69. Lu S, Gough AW, Bobrowski WF, Stewart BH. 1996. Transport properties are not altered across Caco-2 cells with heightened TEER despite underlying physiological and ultrastructural changes. J Pharm Sci 85:270-273.
70. Lentz KA, Hayashi J, Lucisano LJ, Polli JE. 2000. Development of a more rapid, reduced serum culture system for Caco-2 monolayers and application to the biopharmaceutics classification system. Int J Pharm 200:41-51.
71. Bravo SA, Nielsen CU, Amstrup J, Frokjaer S, Bodin B. 2004. In-depth evaluation of Gly-Sar transport parameters as a function of culture time in the Caco-2 cell model. Eur J Pharm Sci 21:77-86.
72. Anderle P, Niederer E, Rubas W, Hilgendorf C, Spahn-Langguth H, Wunderli-Allenspach H, Merkle HP, Langguth P. 1998. P-glycoprotein (P-gp) mediated efflux in Caco-2 cell monolayers: The influence of culturing conditions and drug exposure on P-gp expression levels. J Pharm Sci 87: 757-762.
73. D'Souza VM, Shertzer HG, Menon AG, Pauletti GM. 2003. High glucose concentration in isotonic media alters Caco-2 cell permeability. AAPS PharmSci 5: article 24.
74. D'Souza VM, Buckley DJ, Buckley AR, Pauletti GM. 2003. Extracellular glucose concentration alters functional activity of intestinal oligopeptide transporter (PepT-1) in Caco-2 cells. J Pharm Sci 92:594-603.
75. DeMarco VG, Li N, Thomas J, West CM, Neu J. 2003. Glutamine and barrier function in cultured Caco-2 epithelial cell monolayers. J Nutr 133: 2176-2179.
76. Bestwick CS, Milne L. 2001. Alteration of culture regime modifies antioxidant defenses independent of intracellular reactive oxygen levels and resistance to severe oxidative stress within confluent Caco-2 "intestinal cells". Dig Dis Sci 46:417-423.
77. Ranaldi G, Consalvo R, Sambuy Y, Scarino ML. 2003. Permeability characteristics of parental and clonal human intestinal Caco-2 cell lines differentiated in serum-supplemented and serum-free media. Toxicol In Vitro 17:761-767.
78. Hara A, Hibi T, Toda K, Watanabe N, Hayashi A, Iwao Y, Saito H, Watanabe J, Tsuchiya M. 1993. Changes of proliferative activity and phenotypes in spontaneous differentiation of a colon cancer cell line. Jpn J Cancer Res 84:625-632.
79. Behrens I, Kissel T. 2003. Do cell culture conditions influence the carrier-mediated transport of peptides in Caco-2 cell monolayers? Eur J Pharm Sci 19:433-442.
80. Yuan J, Reyner EL, Stewart BH, Chan OH. 2000. The MDCK monolayer as an in vitro model for membrane permeability screening. AAPS PharmSci 2: abstract 1606.
81. Williams GC, Knipp GT, Sinko PJ. 2003. The effect of cell culture conditions on saquinavir transport through, and interactions with, MDCKII cells overexpressing hM DR1. J Pharm Sci 92:1957-1967.
82. Yu H, Sinko P. 1997. Influence of the microporous substratum and hydrodynamics on resistances of drug transport in cell culture systems: Calculations of intrinsic transport parameters. J Pharm Sci 86:1448-1456.
83. Rothen-Rutishauser B, Braun A, Günthert M, Wunderli-Allenspach H. 2000. Formation of multilayers in the Caco-2 cell culture model: A confocal laser scanning microscopy study. Pharm Res 17: 460-465.
84. Artursson P. 1990. Epithelial transport of drugs in cell cultures: A model for studying the passive diffusion of drugs over intestinal absorptive (Caco-2) cells. J Pharm Sci 79:476-482.
85. Tucker SP, Melsen LR, Compans RW. 1992. Migration of polarized epithelial cells through permeable membrane substrates of defined pore size. Eur J Cell Biol 58:280-290.
86. Markowska M, Oberle R, Juzwin S, Hsu CP, Gryszkiewicz M, Streeter AJ. 2001. Optimizing Caco-2 cell monolayers to increase throughput in drug intestinal absorption analysis. J Pharmacol Toxicol Methods 46:51-55.
87. Kuhfeld MT, Stratford RE. 1996. In vitro measurement of drug transport using a new diffusion chamber compatible with Millicell® culture supports: Performance with Caco-2 monolayers. Int J Pharm 133:47-58.
88. Butor C, Davoust J. 1992. Apical to basolateral surface area ratio and polarity of MDCK cells on different supports. Exp Cell Res 203:115-127.
89. Ward RK, Mungall S, Carter J, Clothier RH. 1997. Evaluation of tissue culture insert membrane compatibility in the fluorescein leakage assay. Toxicol In Vitro 11:761-768.
90. Wilson G. 1990. Cell culture techniques for the study of drug transport. Eur J Drug Metab Pharmacokinet 15:159-163.
91. Sulzbacher A, Jarosch A, Schüler R, Acerbi D, Ventura P, Puccini P, Woodcock BG. 1998. Validation of a Caco-2 cells monolayer culture for drug transport studies. Intl J Clin Pharmacol Ther 36:86-89.
92. Adson A, Burton PS, Raub TJ, Barshun CL, Audus KL, Ho NFH. 1995. Passive diffusion of weak organic electrolytes across Caco-2 cell monolayers: Uncoupling the contributions of hydrodynamic, transcellular and paracellular barriers. J Pharm Sci 84:1197-1204.
93. Pade V, Stavchansky S. 1997. Estimation of the relative contribution of the transcellular and paracellular pathway to the transport of passively absorbed drugs in the Caco-2 cell culture model. Pharm Res 14:1210-1215.
94. Yamashita S, Furubayashim T, Kataoka M, Sakane T, Sezaki H, Tokuda H. 2000. Optimized conditions for prediction of intestinal drug permeability using Caco-2 cells. Eur J Pharm Sci 10:195-204.
95. Lee KJ, Johnson N, Castelo J, Sinko PJ, Grass G, Holme K, Lee YH. 2005. Effect of experimental pH on the in vitro permeability in intact rabbit intestines and Caco-2 monolayer. Eur J Pharm Sci 25: 193-200.
96. 2 incubation in Caco-2 cell. AAPS PharmSci 3: abstract 723.
97. Balimane P, Patel K, Chong S. 2004. Effect of pH on the bidirectional transport of some commonly used efflux (P-gp) substrates. AAPS J 6: abstract 2340.
98. Neuhoff S, Ungell AL, Zamora I, Artursson P. 2005. pH-Dependent passive and active transport of acidic drugs across Caco-2 cell monolayers. Eur J Pharm Sci 25:211-220.
99. Koljonen M, Hakala KS, Ahtola-Satila T, Laitinen L, Kostianen R, Kotiaho T, Kaukonen AM, Hirvonen J. 2006. Evaluation of cocktail approach to standardise Caco-2 permeability experiments. Eur J Pharm Biopharm 29:269-277.
100. Ungell AB, Zamora I, Neuhoff S, Artursson P. 2002. Real and fast efflux of weak basic drugs across Caco-2 monolayers. AAPS PharmSci 4: abstract 5056.
101. Caldwell GW, Easlick SM, Gunnet J, Mausucci JA, Demarest K. 1998. In vitro permeability of eight β-blockers through Caco-2 monolayers utilizing liquid chromatography/electrospray ionization mass spectrometry. J Mass Spectrom 33:607-614.
102. Ho NFH, Raub TJ, Burton PS, Basuhn CL, Adson A, Audus KL, Borchardt RT. 2000. Quantitative approaches to delineate passive transport mechanisms in cell culture monolayers. In: Amidon GL, Lee PI, Topp EM, editors. Transport processes in pharmaceutical systems. NY: Marcel-Dekker, Inc., pp 219-316.
103. Karlsson J, Artursson P. 1992. A new diffusion chamber system for the determination of drug permeability coefficients across the human intestinal epithelium that are independent of the unstirred water layer. Biochim Biophy Acta 1111:204-210.
104. Hidalgo IJ, Hillgren KM, Grass GM, Borchardt RT. 1991. Characterization of the unstirred water layer in Caco-2 cell monolayers using a novel diffusion apparatus. Pharm Res 8:222-227.
105. Bourdage JS, Burton PS, Cole CJ, Conradi RA, Day JS, Hilgers AR, Pfund WP. 1999. Characterization of the Caco-2 permeability model and rat intestinal perfusion model for use with the BCS. AAPS PharmSci 1: abstract 4056.
106. Tolle-Sander S, Polli J. 2002. Method considerations for Caco-2 permeability assessments in the biopharmaceutics classification system. Pharm Forum 28:164-172.
107. Youdin KA, Avdeef A, Abbott NJ. 2003. In vitro trans-monolayer permeability calculations: Often forgotten assumptions. Drug Discov Today 8:997-1003.
108. Palmgrén JJ, Monkkonen J, Korjamo T, Hassinen A, Auriola S. 2006. Drug adsorption to plastic containers and retention of drugs in cultured cells under in vitro conditions. Eur J Pharm Biopharm 64:369-378.
109. Ingels FM, Deferme S, Delbar N, Oth M, Augustijns PF. 2002. Implementation of the Caco-2 cell culture model as a predictive tool for the oral absorption of drugs. In house evaluation procedures. J Pharm Belg 57:153-158.
110. Artursson P, Palm K, Luthman K. 1996. Caco-2 monolayers in experimental and theoretical predictions of drug transport. Adv Drug Deliv Rev 22:67-84.
111. Sambuy Y, DeAngelis I, Ranaldi G, Scarino ML, Stammati A, Zucco F. 2005. The Caco-2 cell line as a model of the intestinal barrier: Influence of cell and culture-related factors on Caco-2 cell functional characteristics. Cell Biol Toxicol 21:1-26.
112. Ungell AL, Karlsson J. 2003. Cell culture in drug discovery: An industrial perspective. In: van de Waterbeen H, Lennernäs H, editors. Drug bioavailability: Estimation of solubility, permeability, absorption and bioavailability. Weinheim: Wiley-VCH. pp 90-131.
113. Hilgers AR, Conradi RA, Burton PS. 1990. Caco-2 cell monolayers as a model for drug transport across the intestinal mucosa. Pharm Res 7:902-910.
114. Hidalgo IJ. 2001. Assessing the absorption of new pharmaceuticals. Curr Top Med Chem 1:385-401.
115. Conradi RA, Wilkinson KF, Rush BD, Hilgers AR, Ruwart MJ, Burton PS. 1993. In vitro/in vivo models for peptide oral absorption: Comparison of Caco-2 cell permeability with rat intestinal absorption of renin inhibitory peptides. Pharm Res 10:1790-1792.
116. Bock U, Flötto T, Haltner E. 2004. Validation of cell culture models for the intestine and the blood brain barrier and comparison of drug permeation. ALTEX 21:57-64.
117. Lee CP, de Vrueh RLA, Philip L, Smith PL. 1997. Selection of development candidates based on in vitro permeability measurements. Adv Drug Deliv Rev 23:47-62.